Mechanisms by which tumor-intrinsic active β-catenin signaling results in T-cell exclusion and resistance to anti-PD-L1/anti-CTLA-4 monoclonal antibody therapy were discovered in an orthotopic mouse model of melanoma. The gene discussed is CD274; the disease is melanoma.